Publications
- OLE study - Open Label Extension study phase Clarinet with lanreotide Autogel 120 mg in metastatic enteropancreatic neuroendocrine tumors2016 | First Faculty of Medicine
- Surgical oncology2014 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- What's new in the treatment of metastatic colorectal cancer after June Gastrointenstinal Congress on Cancer (WCGIC) in Barcelona in 20142014 | First Faculty of Medicine
- The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms2022 | First Faculty of Medicine
- Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study2021 | First Faculty of Medicine
- Expression of molecules of the Wnt pathway and of E-cadherin in the etiopathogenesis of human thymomas2020 | First Faculty of Medicine, Second Faculty of Medicine
- Peptid-receptor radionuklidová terapie v České republice2020 | First Faculty of Medicine, Second Faculty of Medicine
- Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors2020 | First Faculty of Medicine
- Onemocnění slinivky břišní2019 | First Faculty of Medicine, Second Faculty of Medicine
- Neuroendokrinní nádory pankreatu2019 | First Faculty of Medicine
Loading network view...